ENG/中
美国
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Aardvark Therapeutics
7.79
+0.5000
6.86%
盤前:
7.65
-0.1400
-1.80%
06:17 EDT
成交量:
53.10萬
成交額:
336.02萬
市值:
1.67億
市盈率:
-12.02
高:
7.99
開:
7.20
低:
4.88
收:
7.29
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字:
Aardvark Therapeutics
交易所:
NASDAQ
成立時間:
2017
員工人數:
22
公司地址:
4370 La Jolla Village Drive,Suite 1050,San Diego,California,United States
官網:
http://aardvarktherapeutics.com
郵編:
92122
電話:
858 225 7696
傳真:
- -
簡介:
Aardvark Therapeutics, Inc.於2017年5月17日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司,專註於開發新穎的小分子療法,以激活用於治療代謝疾病的先天穩態途徑。該公司瞄準了與緩解飢餓相關的生物途徑,該公司認為這些途徑有可能為患者帶來變革性的結果。該公司已將精力集中在開發選擇性化合物上,針對與飢餓相關的情況開發苦味受體。
董事
名稱
職位
Tien Li Lee
Chief Executive Officer and Director
Jeffrey Chi
Lead Independent Director
Roy D. Baynes
Director
Susan E. Graf
Director
Victor Tong, Jr.
Director
股東
名稱
職位
Tien Li Lee
Chief Executive Officer and Director
Bryan Jones
Chief Operating Officer
Nelson Sun
Chief Financial Officer
Manasi Jaiman
Chief Medical Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AARD/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","market":"US","secType":"STK","nameCN":"Aardvark Therapeutics","latestPrice":7.79,"timestamp":1744228800000,"preClose":7.29,"halted":0,"volume":531017,"hourTrading":{"tag":"盘前","latestPrice":7.65,"preClose":7.79,"latestTime":"06:17 EDT","volume":209,"amount":1442.190079,"timestamp":1744280273872},"delay":0,"floatShares":5900000,"shares":21384400,"eps":-0.648,"marketStatus":"盤前交易","change":0.5,"latestTime":"04-10 07:43:19 EDT","open":7.2,"high":7.99,"low":4.88,"amount":3360202.957994,"amplitude":0.426612,"askPrice":8.05,"askSize":100,"bidPrice":5.8,"bidSize":3,"shortable":0,"etf":0,"ttmEps":-0.648,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1744291800000},"marketStatusCode":1,"adr":0,"listingDate":1739509200000,"exchange":"NASDAQ","adjPreClose":7.79,"preHourTrading":{"tag":"盘前","latestPrice":7.65,"preClose":7.79,"latestTime":"06:17 EDT","volume":209,"amount":1442.190079,"timestamp":1744280273872},"postHourTrading":{"tag":"盘后","latestPrice":7.79,"preClose":7.79,"latestTime":"16:05 EDT","volume":2,"amount":15.58,"timestamp":1744229110360},"volumeRatio":4.078208475715737},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","floatShares":5900000,"roa":"-32.35%","roe":"-50.70%","lyrEps":-0.74,"volumeRatio":4.078208475715737,"shares":21384400,"dividePrice":0,"high":7.99,"amplitude":0.426612,"preClose":7.29,"low":4.88,"week52Low":4.88,"pbRate":"-3.05","week52High":19.58,"institutionHeld":0,"latestPrice":7.79,"committee":-0.941748,"eps":-0.648,"divideRate":0,"volume":531017,"delay":0,"ttmEps":-0.648,"open":7.2,"prevYearClose":16,"prevWeekClose":8.16,"prevMonthClose":7.51,"prevQuarterClose":7.51,"fiveDayClose":9.35,"twentyDayClose":10.14,"sixtyDayClose":16},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":614979892,"yearFounded":2017,"employeeNum":22,"address":"4370 La Jolla Village Drive,Suite 1050,San Diego,California,United States","zipCode":"92122","officePhone":"858 225 7696"},"stockCompanyDetail":{"websiteUrl":"http://aardvarktherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1668},{"period":"1month","weight":-0.2407},{"period":"3month","weight":-0.5131},{"period":"ytd","weight":-0.5131}],"compareEarnings":[{"period":"1week","weight":-0.0282},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0693},{"period":"6month","weight":-0.0534},{"period":"1year","weight":0.0564},{"period":"ytd","weight":-0.0639}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Aardvark Therapeutics, Inc.於2017年5月17日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司,專註於開發新穎的小分子療法,以激活用於治療代謝疾病的先天穩態途徑。該公司瞄準了與緩解飢餓相關的生物途徑,該公司認為這些途徑有可能為患者帶來變革性的結果。該公司已將精力集中在開發選擇性化合物上,針對與飢餓相關的情況開發苦味受體。","exchange":"NASDAQ","name":"Aardvark Therapeutics","nameEN":"Aardvark Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AARD\",market:\"US\",,,undefined,":{"directors":[{"name":"Tien Li Lee","position":"Chief Executive Officer and Director"},{"name":"Jeffrey Chi","position":"Lead Independent Director"},{"name":"Roy D. Baynes","position":"Director"},{"name":"Susan E. Graf","position":"Director"},{"name":"Victor Tong, Jr.","position":"Director"}],"executives":[{"name":"Tien Li Lee","position":"Chief Executive Officer and Director"},{"name":"Bryan Jones","position":"Chief Operating Officer"},{"name":"Nelson Sun","position":"Chief Financial Officer"},{"name":"Manasi Jaiman","position":"Chief Medical Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AARD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"AARD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AARD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AARD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AARD","date":"2025-04-09","current":-7.682303,"percent":1,"low":-51.17654,"twenty":-38.846703,"median":-29.697227,"eighty":-26.516865,"high":-7.682303,"avg":-29.239205,"sd":10.801528,"marketCap":158163256},"quantilePoints":[{"date":"2025-02-21","current":-51.17654,"twenty":-46.993414,"median":-42.216938,"eighty":-39.920668,"marketCap":368880503},{"date":"2025-02-28","current":-39.75453,"twenty":-42.139802,"median":-40.229211,"eighty":-39.232381,"marketCap":286550651},{"date":"2025-03-07","current":-28.243517,"twenty":-40.603022,"median":-39.176012,"eighty":-36.900511,"marketCap":203579269},{"date":"2025-03-14","current":-31.091602,"twenty":-40.336014,"median":-37.766803,"eighty":-30.723725,"marketCap":224108270},{"date":"2025-03-21","current":-27.23482,"twenty":-39.944402,"median":-34.681377,"eighty":-29.198812,"marketCap":196308580},{"date":"2025-03-28","current":-26.404128,"twenty":-39.576524,"median":-30.913597,"eighty":-27.946841,"marketCap":190320955},{"date":"2025-04-04","current":-9.026143,"twenty":-39.119644,"median":-30.068072,"eighty":-27.341623,"marketCap":185830236},{"date":"2025-04-09","current":-7.682303,"twenty":-38.846703,"median":-29.697227,"eighty":-26.516865,"marketCap":158163256}],"updateTime":1744285398649}}}